Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw; Johanna G. van der Bom; Rolf Ljung; Carmen Escuriola; Ana R. Cid; Segolene Claeyssens-Donadel; Christel van Geet; Gili Kenet; Anne Marja-Terttu Mäkipernaa; Angelo Claudio Molinari; Wolfgang Muntean; Rainer Kobelt; George Rivard; Elena Santagostino; Angela Thomas; H. Marijke van den Berg; PedNet RODIN Study Grp

doi:10.1056/NEJMoa1208024

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung, Carmen Escuriola, Ana R. Cid, Segolene Claeyssens-Donadel, Christel van Geet, Gili Kenet, Anne Marja-Terttu Mäkipernaa, Angelo Claudio Molinari, Wolfgang Muntean, Rainer Kobelt, George Rivard, Elena Santagostino, Angela Thomas, H. Marijke van den Berg, PedNet RODIN Study Grp

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	New England Journal of Medicine
Volym	368
Nummer	3
Sidor (från-till)	231-239
Antal sidor	9
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMoa1208024
Status	Publicerad - 17 jan. 2013
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1056/NEJMoa1208024

Citera det här

Gouw, S. C., van der Bom, J. G., Ljung, R., Escuriola, C., Cid, A. R., Claeyssens-Donadel, S., van Geet, C., Kenet, G., Mäkipernaa, A. M.-T., Molinari, A. C., Muntean, W., Kobelt, R., Rivard, G., Santagostino, E., Thomas, A., van den Berg, H. M., & PedNet RODIN Study Grp (2013). Factor VIII Products and Inhibitor Development in Severe Hemophilia A. New England Journal of Medicine, 368(3), 231-239. https://doi.org/10.1056/NEJMoa1208024

@article{f50c0cc1e9314394bab9d85e55be1882,

title = "Factor VIII Products and Inhibitor Development in Severe Hemophilia A",

keywords = "PREVIOUSLY UNTREATED PATIENTS, RECOMBINANT FACTOR-VIII, RISK-FACTORS, MUTATION TYPE, CANAL COHORT, CLASS-II, POLYMORPHISMS, CHILDREN, GENES, 3121 General medicine, internal medicine and other clinical medicine",

author = "Gouw, {Samantha C.} and {van der Bom}, {Johanna G.} and Rolf Ljung and Carmen Escuriola and Cid, {Ana R.} and Segolene Claeyssens-Donadel and {van Geet}, Christel and Gili Kenet and M{\"a}kipernaa, {Anne Marja-Terttu} and Molinari, {Angelo Claudio} and Wolfgang Muntean and Rainer Kobelt and George Rivard and Elena Santagostino and Angela Thomas and {van den Berg}, {H. Marijke} and {PedNet RODIN Study Grp}",

year = "2013",

month = jan,

day = "17",

doi = "10.1056/NEJMoa1208024",

language = "English",

volume = "368",

pages = "231--239",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "3",

}

Gouw, SC, van der Bom, JG, Ljung, R, Escuriola, C, Cid, AR, Claeyssens-Donadel, S, van Geet, C, Kenet, G, Mäkipernaa, AM-T, Molinari, AC, Muntean, W, Kobelt, R, Rivard, G, Santagostino, E, Thomas, A, van den Berg, HM & PedNet RODIN Study Grp 2013, 'Factor VIII Products and Inhibitor Development in Severe Hemophilia A', New England Journal of Medicine, vol. 368, nr. 3, s. 231-239. https://doi.org/10.1056/NEJMoa1208024

TY - JOUR

T1 - Factor VIII Products and Inhibitor Development in Severe Hemophilia A

AU - Gouw, Samantha C.

AU - van der Bom, Johanna G.

AU - Ljung, Rolf

AU - Escuriola, Carmen

AU - Cid, Ana R.

AU - Claeyssens-Donadel, Segolene

AU - van Geet, Christel

AU - Kenet, Gili

AU - Mäkipernaa, Anne Marja-Terttu

AU - Molinari, Angelo Claudio

AU - Muntean, Wolfgang

AU - Kobelt, Rainer

AU - Rivard, George

AU - Santagostino, Elena

AU - Thomas, Angela

AU - van den Berg, H. Marijke

AU - PedNet RODIN Study Grp

PY - 2013/1/17

Y1 - 2013/1/17

KW - PREVIOUSLY UNTREATED PATIENTS

KW - RECOMBINANT FACTOR-VIII

KW - RISK-FACTORS

KW - MUTATION TYPE

KW - CANAL COHORT

KW - CLASS-II

KW - POLYMORPHISMS

KW - CHILDREN

KW - GENES

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1056/NEJMoa1208024

DO - 10.1056/NEJMoa1208024

M3 - Article

SN - 0028-4793

VL - 368

SP - 231

EP - 239

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 3

ER -